• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

拉贝洛尔对眼黑色素的亲和力。

Affinity of labetalol for ocular melanin.

作者信息

Poynter D, Martin L E, Harrison C, Cook J

出版信息

Br J Clin Pharmacol. 1976 Aug;3(4 Suppl 3):711-20.

PMID:990153
Abstract

1 The toxicity of labetalol has been studied in mice, rats, rabbits, and dogs, and reproductive studies have been carried out in rats and rabbits. Nothing was observed in any of these species to suggest that patients taking labetalol might be exposed to any toxic hazard. 2 During the reproductive studies 14C-labetalol was used to study placental transfer. Radioactivity was present in the uveal tract of the foetal eye. 3 Radioactive labetalol but not its metabolites was bound to the melanin pigment of the eye. This binding was reversible. It was not possible to saturate the melanin of the cat and dog eye even with prolonged dosing with labetalol. 4 Chloroquine, given orally at doses of 1.5-6 mg/kg/d for 4-7 weeks, produced changes in the cat retina. When oral doses of 20 mg labetalol/d were given to cats for 7 months, no oculotoxic effects were observed. 5 Detailed ophthalmological and histological examinations were carried out on the rats, rabbits, cats and dogs used in these studies. No changes indicative of oculotoxicity were observed. In the reproductive studies no effects were observed in the developing rat or rabbit eye, which could be consequent on the placental transfer of labetalol or its metabolites.

摘要

1 已在小鼠、大鼠、兔子和狗身上研究了拉贝洛尔的毒性,并在大鼠和兔子身上进行了生殖研究。在这些物种中均未观察到任何迹象表明服用拉贝洛尔的患者可能面临任何毒性危害。2 在生殖研究中,使用14C-拉贝洛尔来研究胎盘转运。放射性物质存在于胎儿眼睛的葡萄膜中。3 放射性拉贝洛尔而非其代谢产物与眼睛的黑色素结合。这种结合是可逆的。即使长期给猫和狗服用拉贝洛尔,也无法使它们眼睛的黑色素饱和。4 氯喹以1.5 - 6毫克/千克/天的剂量口服给药4 - 7周,会使猫的视网膜发生变化。当给猫每天口服20毫克拉贝洛尔,持续7个月时,未观察到眼毒性作用。5 对这些研究中使用的大鼠、兔子、猫和狗进行了详细的眼科和组织学检查。未观察到表明眼毒性的变化。在生殖研究中,未观察到拉贝洛尔或其代谢产物经胎盘转运对发育中的大鼠或兔子眼睛产生任何影响。

相似文献

1
Affinity of labetalol for ocular melanin.拉贝洛尔对眼黑色素的亲和力。
Br J Clin Pharmacol. 1976 Aug;3(4 Suppl 3):711-20.
2
Metabolism of labetalol by animals and man.拉贝洛尔在动物和人体内的代谢。
Br J Clin Pharmacol. 1976 Aug;3(4 Suppl 3):695-710.
3
Absorption, distribution and excretion of 14C-levofloxacin after single oral administration in albino and pigmented rats: binding characteristics of levofloxacin-related radioactivity to melanin in vivo.白化大鼠和有色大鼠单次口服给药后14C-左氧氟沙星的吸收、分布和排泄:左氧氟沙星相关放射性在体内与黑色素的结合特性
J Pharm Pharmacol. 2004 Apr;56(4):463-9. doi: 10.1211/0022357023141.
4
Absorption, distribution and excretion of 14C-chloroquine after single oral administration in albino and pigmented rats: binding characteristics of chloroquine-related radioactivity to melanin in-vivo.白化病大鼠和有色大鼠单次口服给药后14C-氯喹的吸收、分布和排泄:氯喹相关放射性在体内与黑色素的结合特性
J Pharm Pharmacol. 2003 Dec;55(12):1647-54. doi: 10.1211/0022357022340.
5
[On the acute toxicity of labetalol (AH-5158), a combined alpha-and-beta-adrenoceptor-blocking agent (author's transl)].
Hokkaido Igaku Zasshi. 1978 Jan;53(1):15-21.
6
Pharmacokinetics and tissue distribution of ketanserin in rat, rabbit and dog.酮色林在大鼠、兔和犬体内的药代动力学及组织分布
Arzneimittelforschung. 1988 Jun;38(6):775-84.
7
Binding of drugs to eye melanin is not predictive of ocular toxicity.药物与眼部黑色素的结合并不能预测眼部毒性。
Regul Toxicol Pharmacol. 1998 Oct;28(2):124-32. doi: 10.1006/rtph.1998.1243.
8
The melanin binding of bisoprolol and its toxicological relevance.比索洛尔与黑色素的结合及其毒理学意义。
Lens Eye Toxic Res. 1990;7(3-4):319-33.
9
The metabolism of labetalol in animals and man.拉贝洛尔在动物和人体内的代谢。
Biochem Soc Trans. 1976;4(4):726-9. doi: 10.1042/bst0040726.
10
Comparative assessment of ocular tissue distribution of drug-related radioactivity after chronic oral administration of 14C-levofloxacin and 14C-chloroquine in pigmented rats.色素沉着大鼠长期口服14C-左氧氟沙星和14C-氯喹后药物相关放射性在眼部组织分布的比较评估。
J Pharm Pharmacol. 2004 Aug;56(8):977-83. doi: 10.1211/0022357043932.

引用本文的文献

1
Clinical pharmacokinetics of labetalol.拉贝洛尔的临床药代动力学
Clin Pharmacokinet. 1984 Mar-Apr;9(2):157-67. doi: 10.2165/00003088-198409020-00003.
2
Pharmacology of combined alpha-beta-blockade. I.α-β联合阻滞的药理学。I.
Drugs. 1984;28 Suppl 2:16-34. doi: 10.2165/00003495-198400282-00003.
3
Use of labetalol in the treatment of severe hypertension during pregnancy.拉贝洛尔在妊娠期重度高血压治疗中的应用。
Br J Clin Pharmacol. 1979;8(Suppl 2):211S-215S.
4
A long-term study of labetalol in general practice.拉贝洛尔在全科医疗中的长期研究。
Br J Clin Pharmacol. 1979;8(Suppl 2):167S-170S.
5
Labetalol: a review of its pharmacology and therapeutic use in hypertension.拉贝洛尔:其药理学及在高血压治疗中的应用综述
Drugs. 1978 Apr;15(4):251-70. doi: 10.2165/00003495-197815040-00002.